Biography of Shane Schaffer
Shane Schaffer is the co-founder, chairman, and chief executive officer of Cingulate Therapeutics in Kansas City, Kansas. In Phase 3 clinical-stage development, this company focuses on creating and managing several branded, next-generation pharmaceutical products. Notably engaged in addressing Attention Deficit/Hyperactivity Disorders (ADHD), it also covers other therapeutic areas such as anxiety disorders and insomnia. With a 25-year track record in the pharmaceutical industry, he specializes in drug development and commercialization. His effective leadership and entrepreneurial approach in product